Please login to the form below

Not currently logged in
Email:
Password:

life expectancy

This page shows the latest life expectancy news and features for those working in and with pharma, biotech and healthcare.

AstraZenca to appeal NICE rejection of Tagrisso

AstraZenca to appeal NICE rejection of Tagrisso

This is defined, along with other criteria, as treatment which is given to patients whose life expectancy is normally less than 24 months. ... to help deliver the government’s ambition that the UK continues to be a globally leading centre for life

Latest news

More from news
Approximately 1 fully matching, plus 100 partially matching documents found.

Latest Intelligence

  • The true potential of mobile health tech The true potential of mobile health tech

    So, if life expectancy and health behaviour are directly correlated,. it should follow that if we can create an environment where people are more active within their health,. ... we can influence their health-related quality of life at a population level.

  • Is AI changing the future of healthcare? Is AI changing the future of healthcare?

    Life expectancy around the globe continues to rise and so the need for new treatments and a greater understanding of what’s happening in our societies health-wise is at an ... For example, an AI programme named Woebot has been created to act like an

  • The real-world data conundrum The real-world data conundrum

    This change is affecting all stakeholders. From a drug development perspective, a new data science is driving a paradigm shift in the product life cycle. ... Is this realistic? Or rather, is this within our grasp? The high levels of innovation understood

  • A healthy challenge A healthy challenge

    There are further stark gaps in life expectancy between the least and most educated, and the poorest and richest, says the report. ... On average across EU countries, the life expectancy of people with the lowest level of education is seven years shorter

  • Should we be concerned about medical progress? Should we be concerned about medical progress?

    We are considering an innovation that is raising life expectancy at age 50 by about one year and induces about $20, 000 in additional healthcare expenditure over a representative individual's ... Finally, mortality-reducing medical innovations tend to

More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics